The current JBCB issue presents full papers on bioinformatics and computational biology from SBB'2017, reporting research on promoter prediction, algorithm optimization, mRNA modeling and database applications. These papers are brie°y described in what follows.
Krasnov et al. 8 presented MethyMer, a Python-based tool aimed at selecting primers for ampli¯cation of complete CpG islands. These regions are di±cult in terms of selecting appropriate primers because of their low complexity and high GC content. MethyMer has a°exible scoring system that optimizes the balance between various characteristics such as nucleotide composition, thermodynamic features, presence of CpG sites and primer speci¯city, which is assessed with aligning primers to the bisul¯te-treated genome using Bowtie. MethyMer incorporates ENCODE genome annotation records (promoter/enhancer/insulator), The Cancer Genome Atlas (TCGA) CpG methylation data derived with Illumina In¯nium 450K microarrays, and records on correlations between TCGA RNA-Seq and CpG methylation data for 20 cancer types.
Ryasik et al. 9 used a machine learning approach for bacterial promoter prediction. Predicting promoter activity of a DNA fragment is an important task for computational biology. To select an adequate set of physical properties of DNA for training a classi¯er, various characteristics of DNA molecule should be taken into consideration. A systematic approach allowing selection of the least correlated properties for classi¯cation by means of both correlation and cophenetic coe±cients as well as concordance matrices was presented. The proposed classi¯er uses not only sequence and static physical properties of DNA fragment, but also dynamic properties of DNA open state. Therefore, the best performing models with accuracy values up to 90% for all types of sequences were obtained. It was demonstrated that the classi¯er can serve as a reliable tool enabling promoter DNA fragments to be distinguished from promoter islands despite the similarity of their nucleotide sequences.
Vishnevsky et al. 10 presented optimization approaches for high-performance GPU technologies. Their Argo CUDA web service was designed to process massive DNA data. It is a program for the detection of degenerate oligonucleotide motifs of¯xed length written in 15-letter IUPAC code. Despite di®erent tools and stochastic approaches, the e±ciency of the motif discovery programs dramatically declines as query set size increases. Argo CUDA is a full-exhaustive approach based on highperformance GPU technologies. The authors showed e®ective prediction of ChIP-Seq sequences on simulated sets.
Kiseleva et al. 11 describe tools for mass-spectrometry analysis. The necessity of single-thread analysis of bulky data emerged during interpretation of HepG2 proteome pro¯ling results for proteoforms searching. The authors compared contribution of each of eight search engines (X!Tandem, MS-GFþ, MS Amanda, MyriMatch, Comet, Tide, Andromeda, and OMSSA) integrated in an open-source graphical user interface SearchGUI into total result of proteoforms identi¯cation and optimized set of engines working simultaneously. Most e±cient combination of the tools was selected.
Antonov et al. 12 described a new computational pipeline, ASSA, combining sequence alignment and thermodynamics-based tools for e±cient prediction of RNA-RNA interactions between long transcripts. The discovery of thousands of long noncoding RNAs (lncRNAs) in mammals raises a question about their functionality including prediction of RNA-RNA interactions. Sequence alignment tools have been used for transcriptome-wide prediction of RNA-RNA interactions; but they have poor prediction accuracy since they ignore RNA secondary structure. The novelty of ASSA is its ability to quickly estimate the statistical signi¯cance of the observed interaction energies. The authors showed that ASSA outperforms eleven other tools.
Ovchinnikov et al. 13 presented a case study for transcription factor binding site search in promoters of intronic and intergenic microRNAs. Some exogenous compounds or xenobiotics may a®ect microRNA expression. Authors hypothesized that such chemicals can a®ect miRNA expression through the activation of aryl hydrocarbon receptor (AHR), the nuclear receptor CAR, and estrogen receptors (ESRs). To support this claim, they used in silico methods to¯nd potential binding sites for these receptors, and predicted AhR, CAR and ESRs binding sites in rat, mouse and human promoters of miRNA-coding genes that open a new strategy for ongoing experimental studies and will contribute to further investigation of epigenetic mechanisms of carcinogenesis.
Kazantsev et al. 14 presented the MAMMOTh: the database for curated MAthematical Models of bioMOlecular systems. MAMMOTh database entries are organized as building blocks in a way that the model parts can be used in di®erent combinations to describe systems with higher organizational level (metabolic pathways and/or transcription regulatory networks). The tool supports export of a single model or their combinations in SBML or Mathematica standards. The database currently contains 110 mathematical sub models for Escherichia coli elementary subsystems (enzymatic reactions and gene expression regulatory processes) that can be combined in at least 5100 complex/sophisticated models concerning more complex biological processes as de novo nucleotide biosynthesis, aerobic/anaerobic respiration and nitrate/nitrite utilization in E. coli.
Bezhentsev et al. 15 presented a network pharmacology approach to search potential drug targets for treatment of refractory epilepsy. Epilepsy is the fourth most common neurological disease after a migraine, stroke and Alzheimer's disease. Approximately one-third of all epilepsy cases are refractory to the existing anticonvulsants. Discovery of newer antiepileptic drugs for treating refractory epilepsy is a challenging problem due to unclear etiology of this disease. In this regard, network pharmacology as an area of bioinformatics is gaining popularity. It combines methods of network biology and polypharmacology, which makes it a promising approach for¯nding new molecular targets. This paper is dedicated to the discovery of new pharmacological targets for treatment of refractory epilepsy using network pharmacology methods.
